This new publication proposes an analyzis of pharma companies’ reputation and practical recommendations to improve the opinion of their core stakeholders.
News
This document shares essential recommendations to help pharma companies develop business forecasting, based on academic methods and...
The quality of Medical Brand Plans is often sub-optimal due to aweak building process, a lack of...
Brand plans are often of limited value due to a weak development process, insufficient market insights, and...